Please use this identifier to cite or link to this item:
https://doi.org/10.1080/14737167.2023.2295474
| Title: | Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore | Authors: | Elaine Hsuen Lim Andrew Lim Jasmeet Singh Khara John Cheong Jek Fong Sivabalan Sivanesan Matt Griffiths Emma New Soo-chin Lee |
Issue Date: | 30-Jan-2024 | Publisher: | Taylor & Francis | Citation: | Elaine Hsuen Lim, Andrew Lim, Jasmeet Singh Khara, John Cheong, Jek Fong, Sivabalan Sivanesan, Matt Griffiths, Emma New, Soo-chin Lee (2024-01-30). Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore. Expert Review of Pharmacoeconomics & Outcomes Research 24 (3) : 413-426. ScholarBank@NUS Repository. https://doi.org/10.1080/14737167.2023.2295474 | Source Title: | Expert Review of Pharmacoeconomics & Outcomes Research | URI: | https://scholarbank.nus.edu.sg/handle/10635/247511 | ISSN: | 1473-7167 | DOI: | 10.1080/14737167.2023.2295474 |
| Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| 10.108014737167.2023.2295474.zip | 2.19 MB | ZIP | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.